Annual accounts receivable:
$1.06B+$94.25M(+9.79%)Summary
- As of today (June 7, 2025), RDY annual accounts receivable is $1.06 billion, with the most recent change of +$94.25 million (+9.79%) on March 1, 2025.
- During the last 3 years, RDY annual accounts receivable has risen by +$176.62 million (+20.06%).
- RDY annual accounts receivable is now at all-time high.
Performance
RDY Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$1.06B-$17.82M(-1.66%)Summary
- As of today (June 7, 2025), RDY quarterly accounts receivable is $1.06 billion, with the most recent change of -$17.82 million (-1.66%) on March 1, 2025.
- Over the past year, RDY quarterly accounts receivable has increased by +$94.25 million (+9.79%).
- RDY quarterly accounts receivable is now -1.66% below its all-time high of $1.07 billion, reached on December 31, 2024.
Performance
RDY Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RDY Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.8% | +9.8% |
| 3 y3 years | +20.1% | +20.1% |
| 5 y5 years | +58.6% | +58.6% |
RDY Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +20.1% | -1.7% | +26.2% |
| 5 y | 5-year | at high | +58.6% | -1.7% | +71.9% |
| alltime | all time | at high | +1961.0% | -1.7% | +1798.6% |
RDY Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $1.06B(+9.8%) | $1.06B(-1.7%) |
| Dec 2024 | - | $1.07B(+6.6%) |
| Sep 2024 | - | $1.01B(+3.8%) |
| Jun 2024 | - | $971.68M(+0.9%) |
| Mar 2024 | $962.85M(+9.1%) | $962.85M(+2.5%) |
| Dec 2023 | - | $939.36M(+12.1%) |
| Sep 2023 | - | $837.92M(-10.8%) |
| Jun 2023 | - | $939.33M(+6.4%) |
| Mar 2023 | $882.87M(+0.3%) | $882.87M(-2.6%) |
| Dec 2022 | - | $906.78M(-4.0%) |
| Sep 2022 | - | $944.86M(+1.8%) |
| Jun 2022 | - | $927.91M(+5.4%) |
| Mar 2022 | $880.48M(+30.3%) | $880.48M(+4.9%) |
| Dec 2021 | - | $838.96M(-9.1%) |
| Sep 2021 | - | $923.16M(+12.4%) |
| Jun 2021 | - | $821.42M(+21.5%) |
| Mar 2021 | $675.86M(+1.4%) | $675.86M(-6.6%) |
| Dec 2020 | - | $723.84M(+7.1%) |
| Sep 2020 | - | $675.89M(+9.9%) |
| Jun 2020 | - | $614.79M(-7.8%) |
| Mar 2020 | $666.64M(+16.1%) | $666.64M(+7.4%) |
| Dec 2019 | - | $620.49M(+7.5%) |
| Sep 2019 | - | $577.14M(+5.7%) |
| Jun 2019 | - | $545.76M(-4.9%) |
| Mar 2019 | $574.07M(-8.0%) | $574.07M(+8.0%) |
| Dec 2018 | - | $531.73M(-16.4%) |
| Sep 2018 | - | $636.16M(-8.6%) |
| Jun 2018 | - | $696.38M(+11.6%) |
| Mar 2018 | $623.88M(+6.3%) | $623.88M(-6.1%) |
| Dec 2017 | - | $664.49M(+2.9%) |
| Sep 2017 | - | $645.71M(+1.7%) |
| Jun 2017 | - | $634.79M(+8.1%) |
| Mar 2017 | $586.96M(-5.6%) | $586.96M(-3.0%) |
| Dec 2016 | - | $605.27M(+9.5%) |
| Sep 2016 | - | $552.61M(+5.0%) |
| Jun 2016 | - | $526.45M(-15.4%) |
| Mar 2016 | $622.07M(-4.5%) | $622.07M(-1.3%) |
| Dec 2015 | - | $630.24M(-3.0%) |
| Sep 2015 | - | $649.88M(-1.5%) |
| Jun 2015 | - | $659.45M(+1.2%) |
| Mar 2015 | $651.67M(+18.0%) | $651.67M(+2.7%) |
| Dec 2014 | - | $634.33M(+3.5%) |
| Sep 2014 | - | $612.61M(+1.9%) |
| Jun 2014 | - | $601.23M(+8.9%) |
| Mar 2014 | $552.05M(-6.1%) | $552.05M(-2.0%) |
| Dec 2013 | - | $563.26M(+6.5%) |
| Sep 2013 | - | $528.99M(+9.2%) |
| Jun 2013 | - | $484.48M(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | $587.65M(+19.1%) | $587.65M(+19.8%) |
| Dec 2012 | - | $490.70M(-0.9%) |
| Sep 2012 | - | $495.02M(+12.6%) |
| Jun 2012 | - | $439.56M(-10.9%) |
| Mar 2012 | $493.35M(+25.0%) | $493.35M(-0.8%) |
| Dec 2011 | - | $497.13M(+18.2%) |
| Sep 2011 | - | $420.62M(+10.0%) |
| Jun 2011 | - | $382.30M(-3.1%) |
| Mar 2011 | $394.58M(+48.0%) | $394.58M(+25.6%) |
| Dec 2010 | - | $314.27M(+5.1%) |
| Sep 2010 | - | $298.95M(+8.8%) |
| Jun 2010 | - | $274.79M(+3.1%) |
| Mar 2010 | $266.59M(-7.4%) | $266.59M(+6.6%) |
| Dec 2009 | - | $250.04M(-9.1%) |
| Sep 2009 | - | $274.94M(-4.5%) |
| Mar 2009 | $287.90M(+69.3%) | $287.90M(+7.3%) |
| Dec 2008 | - | $268.40M(+20.3%) |
| Sep 2008 | - | $223.17M(+8.5%) |
| Jun 2008 | - | $205.63M(+20.9%) |
| Mar 2008 | $170.10M(-2.9%) | $170.10M(-14.0%) |
| Dec 2007 | - | $197.85M(-6.5%) |
| Sep 2007 | - | $211.60M(+20.1%) |
| Jun 2007 | - | $176.16M(+0.6%) |
| Mar 2007 | $175.09M(+61.9%) | $175.09M(+27.6%) |
| Dec 2006 | - | $137.23M(-35.9%) |
| Sep 2006 | - | $214.25M(+1.5%) |
| Jun 2006 | - | $211.06M(+95.2%) |
| Mar 2006 | $108.12M(+31.4%) | $108.12M(+7.8%) |
| Dec 2005 | - | $100.29M(+1.1%) |
| Sep 2005 | - | $99.18M(+9.6%) |
| Jun 2005 | - | $90.50M(+10.0%) |
| Mar 2005 | $82.26M(-4.6%) | $82.26M(-4.1%) |
| Dec 2004 | - | $85.77M(-4.0%) |
| Sep 2004 | - | $89.34M(-1.5%) |
| Jun 2004 | - | $90.73M(+5.2%) |
| Mar 2004 | $86.27M(+15.6%) | $86.27M(-5.4%) |
| Dec 2003 | - | $91.15M(-1.4%) |
| Sep 2003 | - | $92.46M(+1.8%) |
| Jun 2003 | - | $90.79M(+21.6%) |
| Mar 2003 | $74.64M(-4.4%) | $74.64M(-6.5%) |
| Dec 2002 | - | $79.83M(+1.8%) |
| Sep 2002 | - | $78.41M(+6.6%) |
| Jun 2002 | - | $73.53M(-5.9%) |
| Mar 2002 | $78.11M(+52.3%) | $78.11M(-3.2%) |
| Dec 2001 | - | $80.69M(-12.3%) |
| Sep 2001 | - | $92.00M(+65.2%) |
| Jun 2001 | - | $55.68M |
| Mar 2001 | $51.29M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual accounts receivable?
- What is the all time high annual accounts receivable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual accounts receivable year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly accounts receivable year-on-year change?
What is Dr Reddys Laboratories Limited annual accounts receivable?
The current annual accounts receivable of RDY is $1.06B
What is the all time high annual accounts receivable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual accounts receivable is $1.06B
What is Dr Reddys Laboratories Limited annual accounts receivable year-on-year change?
Over the past year, RDY annual accounts receivable has changed by +$94.25M (+9.79%)
What is Dr Reddys Laboratories Limited quarterly accounts receivable?
The current quarterly accounts receivable of RDY is $1.06B
What is the all time high quarterly accounts receivable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly accounts receivable is $1.07B
What is Dr Reddys Laboratories Limited quarterly accounts receivable year-on-year change?
Over the past year, RDY quarterly accounts receivable has changed by +$94.25M (+9.79%)